Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
neurotoxicity: inhalation
Remarks:
developmental neurotoxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Cross-reference
Reason / purpose for cross-reference:
reference to same study
Reference
Endpoint:
developmental toxicity
Remarks:
developmental neurotoxicity
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Reason / purpose for cross-reference:
reference to same study
Qualifier:
equivalent or similar to guideline
Guideline:
other: US EPA OPPTS 870.6300
Version / remarks:
not specified, (OPP 83–6 Developmental Neurotoxicity Study (Pesticide Assessment Guidelines, Subdivision F--Hazard Evaluation: Human and Domestic Animals, Addendum 10, EPA report 540/09– 91–123, March 1991)
Deviations:
yes
Remarks:
Only one concentration instead of three concentrations tested. Only tested until day 20 of gestation instead of day-10 postnatally. Only 16 (14 for the control) instead of 20 litters.
GLP compliance:
not specified
Specific details on test material used for the study:
Source: BASF AG, Ludwigshafen, Germany, commercial grade
Purity: at least 99.5%
Species:
rat
Strain:
Wistar
Remarks:
Mol:Wist
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: not specified
- Exposed sex: females
- Nulliparous: yes
- Age at study initiation: not specified
- Weight at study initiation: 100-120 g
- Fasting during study: food and water removed during exposure
- Housing:
- in pairs, wire mesh cages
- after exposure, on post coitum (PC) day 20: housed alone, plastic cages
- Diet: ad libitum; Altromin Standard Diet nr. 1324
- Water: e.g. ad libitum, tap water
- Acclimation period: 1-day adaptation period to the whole-body inhalation chambers

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 (22-25 in the inhalation chambers)
- Humidity (%): 40-60 % (30-50 % in the inhalation chambers)
- Air changes (per hr): 8 (dynamic air flow of 12 air changes per hour during exposure)
- Photoperiod (hrs dark / hrs light): 12 / 12
Route of administration:
inhalation: vapour
Type of inhalation exposure (if applicable):
whole body
Vehicle:
air
Details on exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: not specified
- Source and rate of air: not specified
- Method of conditioning air: heated in a glass spiral heated by circulation of warm water
- Temperature in air chamber: ca. 22-25°C
- Treatment of exhaust air: not specified

TEST ATMOSPHERE
- Brief description of analytical method used:
- infrared gascell spectrophotometer (MIRAN-1A from Foxboro) was used to monitor the concentration of NMP continously; the spectrophotometer was calibrated daily
- air samples from charcoal tubes were regularly analysed by GC (HP5720A with 3380 A integrator, 6 feetx 1/8" SS column with 0.1% SP1000 80/100 mesh Carbopack)

- Samples taken from breathing zone: no
Details on mating procedure:
- Impregnation procedure: cohoused
- M/F ratio per cage: 1/1
- Length of cohabitation: from 6 a.m. to 12 p.m.
- Proof of pregnancy:sperm in vaginal smear referred to as day 0 of pregnancy
Duration of treatment / exposure:
day 7 through day 20 of gestation
Frequency of treatment:
6 h/d
Duration of test:
21 d
Dose / conc.:
150 ppm (analytical)
Remarks:
equivalent to 0.618 L/min or 620 mg/m3
No. of animals per sex per dose:
not specified, 37 sperm-positive females
Control animals:
yes, concurrent no treatment
Details on study design:
- Dose selection rationale: dose level and exposure period were chosen to minimize maternal toxicity and offspring mortality
Maternal examinations:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily after exposure

DETAILED CLINICAL OBSERVATIONS: No data

BODY WEIGHT: Yes
- Time schedule for examinations: gestational day (GD 1, 7, 10, 15 and 20)

POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on postnatal day 22 of weaning females; rest of the dams and sperm-positive females observed right after sacrifice
- Organs examined: not specified, macrospcopical changes examined
Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: No data
- Number of implantations: Yes
- Number of early resorptions: No data
- Number of late resorptions: No data
Fetal examinations:
- External examinations: Yes: all per litter
- Soft tissue examinations: No data
- Skeletal examinations: No data
- Head examinations: Yes: all per litter
- Behavioral test: surface rightening reflex; homing response; auditory startle reflex; air rightening reflex; rotarod test; open field and Morris water maze test for training, learning, retention, transfer, new platform location and operant conditioning
Results are given in table 1.
Statistics:
- litter or one pup per litter = statistical unit
- Mann-Whitney U test and chi-square test: body weights, developmental milestones and reflexes, results from Rotarod test
- Multivariant analyses (MANOVA): Morris maze results, operant behavior test
Historical control data:
Because a pilot study had indicated that fetal viability was not affected by the chosen dose level and exposure period, the size of the litters was not standardized in the present study.
Clinical signs:
no effects observed
Description (incidence and severity):
- no clinical signs were seen
Body weight and weight changes:
no effects observed
Description (incidence and severity):
- no effects observed compared to the control group
Urinalysis findings:
effects observed, non-treatment-related
Description (incidence and severity):
- urine of the females in the exposed group was colored bright yellow
Description (incidence and severity):
Migrated Data from removed field(s)
Field "Effects on pregnancy duration" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.EffectsOnPregnancyDuration): no effects observed
Field "Description (incidence and severity)" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.DescriptionIncidenceAndSeverityEffectsOnPregnancyDuration): - no effects observed compared to the control group
Changes in number of pregnant:
no effects observed
Description (incidence and severity):
- no effects observed compared to the control group
Dose descriptor:
NOAEC
Effect level:
150 ppm (analytical)
Based on:
test mat.
Remarks on result:
other: equivalent to 620 mg/m3
Abnormalities:
no effects observed
Fetal body weight changes:
effects observed, treatment-related
Description (incidence and severity):
- from birth and throughout preweaning: mean b.w. in litters was significantly lower
- distribution of b.w. was not merely shifted to lower values also more skewed
- difference was not statistically significant after the age of 5 weeks
Results are given in table 2 and table 3.
Reduction in number of live offspring:
no effects observed
Description (incidence and severity):
- no effects observed compared to the control group
Changes in sex ratio:
no effects observed
Description (incidence and severity):
- no effects observed compared to the control group
External malformations:
effects observed, treatment-related
Description (incidence and severity):
- significantly delayed in some recorded developmental milestones
Skeletal malformations:
not examined
Visceral malformations:
not examined
Other effects:
effects observed, treatment-related
Description (incidence and severity):
Behavioral effects:
- exposed pups were significantly delayed in some recorded developmental milestones and in the ontogeny of the surface righting reflex (see Table 4)
- no differences found concerning age at sexual maturation, performance on the Rotarod, or ambulation and percentage of time spent in the center square in open field
- testing for operant behavior indicated no differences in the first training phases concerning outshaping, discrete trials, or visual discrimination
- suggested reduced retention of learned behavior
Dose descriptor:
LOAEC
Effect level:
150 ppm (analytical)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
fetal/pup body weight changes
external malformations
other: Behavior: impairments of higher cognitive functions (solving difficult tasks)
Remarks on result:
other: equivalent to 620 mg/m3
Abnormalities:
no effects observed
Description (incidence and severity):
insufficient parameter analyzed
Developmental effects observed:
no
Lowest effective dose / conc.:
150 ppm (analytical)
Treatment related:
no

Table 2: Pup body weights.

Body weight after weaning

 

Control

NMP

Females

Small*

 

Medium†

 

Small*

 

Medium†

 

Day 22

41± 1

 

42 ± 1

 

37 ± 1§

 

39 ± 1†

 

Day 24

45± 1

 

48 ± 1

 

41 ± 1§

 

44 ± †

 

Day 28 or 29

61 ± 2

 

65 ± 1

 

60 ± 2

 

62 ± 2

 

7-8 weeks

155± 4

 

165 ± 5

 

147 ±3

 

155 ± 4§

 

11-12 weeks

197± 5

 

210 ± 6

 

190 ± 4

 

201 ± 4

 

Males

 

 

 

 

 

 

 

 

Day 22

41± 1

 

43 ± 1

 

39 ± 1§

 

40 ± 1‡

 

Day 24

47 ± 1

 

48 ± 1

 

43 ± 1§

 

44± 1‡

 

Day 28

65 ± 1

 

68 ± 1

 

62 ± 1

 

66 ± 1

 

Day 36 (± 1)

108 ± 3

 

113 ± 3

 

104 ± 3

 

105 ± 3‡

 

7-8 weeks

218 ± 7

 

221 ± 6

 

209 ± 6

 

206 ± 7

 

11-12 weeks

335 ± 11

 

340 ± 7

 

320 ± 6

 

327 ± 7

 

14-15 weeks

368 ± 13

 

375 ± 8

 

346 ± 8

 

354 ± 8

 

*Pup with lowest body weight in litter at weaning;†Pup with median body weight in litter at weaning;‡p<0.05,Mann-Whitney U Test, NMP versus control;§p<0.10, Mann-Whitney U Test, NMP versus control; mean ± SD.

Table 3: Body weight in litters in the preweaning period.

Group

Control

NMP

Number of litters

14

16

Day 1

5.9 ± 0.4

5.5 ± 0.3*

Day 7

12.8 ± 0.9

11.9 ± 1.0*

Day 10

17.6 ± 1.3

16.6 ± 1.6*

Day 14

24.0 ± 1.7

22.6 ± 2.0*

Day 19

32.5 ± 3.2

30.S ± 2.7†

Day 22

42.2 ± 3.7

39.S ± 3.3*

*p<0.05,Mann-Whitney U Test; p<0.10, Mann­ Whitney U Test; Mean±SD.

Table 4: Results of the developmental milestones and the reflex testing in exposed pups.

Developmental milestones and reflexes

 

 

Control

NMP

Number of litters

 

14

16

Ear unfolding

positive - day 2

2%

0%

 

positive - day 3

88%

48%*

Surface righting reflex

negative - day 1

50%

59%

 

negative - day 2

negative - day 3

41%

6%

39%

15%

 

negative - day 4

O%

3%

Homing response

positive - day 6

67%

77%

 

positive - day 7

95%

95%

Incisor eruption

positive - day 9

positive - day 10

14%

50%

8%

37%

 

positive - day 11

91%

77%

 

positive - day 12

99%

93%

Auditory startle reflex

positive - day 11

0%

0%

 

positive . day 12

11%

5%

 

positive- day 13

93%

77%

Eye opening

positive - day 13

6%

9%

 

positive - day 14

44%

43%

 

positive. day 15

98%

83%*

Air righting reflex

positive- day 14

26%

32%

 

positive. day 15

53%

49%

 

positive- day 16

98%

99%

Mean of%of litters;*p<5%,Mann-Whitney U Test;p<5%,x2-test.

Conclusions:
The physical development of the pups was delayed based on retarded body weight gain until weaning and the results of ear unfolding, surface rightening reflex, incisor eruption and eye opening. However, no treatment-related effects were noted on landmarks of physical development and reflexes during the later part of pre-weaning and thereafter and no effects on onset of puberty, open filed parameter and performance on rotarod. The results of the Morris water maze and operant conditioning were contradictory since some parameter and sessions showed an impairment, while other demonstrated no differences.
Executive summary:

Pregnant rats (Mol: WIST) were exposed to 150 ppm N-methylpyrrolidone for 6 hours per day on gestation days 7-20 (Hass et al., 1994). The dose level was selected so as not to induce maternal toxicity or decrease viability of the offspring. In the preweaning period, the exposed offspring had a lower body weight and their physical development was delayed. Neurobehavioral evaluation of the male pups revealed no effects on basal functions of the central nervous system. The animals appeared normal in motor function (rotarod), activity level (open field), and performance in learning tasks with a low grade of complexity were similar in the two groups. However, in more difficult tasks such as the reversal procedure in Morris water maze and operant delayed spatial alternation (Skinner boxes), performance was impaired in exposed offspring.

Data source

Reference
Reference Type:
publication
Title:
Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behavior in rats
Author:
Hass U., Lund S.P., Elsner J.
Year:
1994
Bibliographic source:
Neurotoxicol. Teratol., 16(3), 241-249

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
EPA OPPTS 870.6300 (Developmental Neurotoxicity Study)
Version / remarks:
not specified, (OPP 83–6 Developmental Neurotoxicity Study (Pesticide Assessment Guidelines, Subdivision F--Hazard Evaluation: Human and Domestic Animals, Addendum 10, EPA report 540/09– 91–123, March 1991)
Deviations:
yes
Remarks:
Only one concentration instead of three concentrations tested. Only tested until day 20 of gestation instead of day-10 postnatally. Only 16 (14 for the control) instead of 20 litters. Examinations differ from guideline and are given in table 1.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
1-methyl-2-pyrrolidone
EC Number:
212-828-1
EC Name:
1-methyl-2-pyrrolidone
Cas Number:
872-50-4
Molecular formula:
C5H9NO
IUPAC Name:
1-methylpyrrolidin-2-one
Test material form:
liquid
Specific details on test material used for the study:
Source: BASF AG, Ludwigshafen, Germany, commercial grade
Purity: at least 99.5%

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: not specified
- Exposed sex: females
- Nulliparous: yes
- Age at study initiation: not specified
- Weight at study initiation: 100-120 g
- Fasting during study: food and water removed during exposure
- Housing:
- in pairs, wire mesh cages
- after exposure, on post coitum (PC) day 20: housed alone, plastic cages
- Diet: ad libitum; Altromin Standard Diet nr. 1324
- Water: e.g. ad libitum, tap water
- Acclimation period: 1-day adaptation period to the whole-body inhalation chambers

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 (22-25 in the inhalation chambers)
- Humidity (%): 40-60 % (30-50 % in the inhalation chambers)
- Air changes (per hr): 8 (dynamic air flow of 12 air changes per hour during exposure)
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:
inhalation: vapour
Vehicle:
air
Details on exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: not specified
- Source and rate of air: not specified
- Method of conditioning air: heated in a glass spiral heated by circulation of warm water
- Temperature in air chamber: ca. 22-25°C
- Treatment of exhaust air: not specified

TEST ATMOSPHERE
- Brief description of analytical method used:
- infrared gascell spectrophotometer (MIRAN-1A from Foxboro) was used to monitor the concentration of NMP continously; the spectrophotometer was calibrated daily
- air samples from charcoal tubes were regularly analysed by GC (HP5720A with 3380 A integrator, 6 feetx 1/8" SS column with 0.1% SP1000 80/100 mesh Carbopack)

- Samples taken from breathing zone: no
Duration of treatment / exposure:
day 7 through day 20 of gestation
Frequency of treatment:
6 h/d
Doses / concentrations
Dose / conc.:
150 ppm (analytical)
Remarks:
equivalent to 0.618 L/min or 620 mg/m3
No. of animals per sex per dose:
not specified, 37 sperm-positive females
Control animals:
yes, concurrent no treatment
Details on study design:
- Dose selection rationale: dose level and exposure period were chosen to minimize maternal toxicity and offspring mortality

Examinations

Observations and clinical examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily after exposure

DETAILED CLINICAL OBSERVATIONS: No data

BODY WEIGHT: Yes
- Time schedule for examinations: gestational day (GD 1, 7, 10, 15 and 20)

POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on postnatal day 22 of weaning females; rest of the dams and sperm-positive females observed right after sacrifice
- Organs examined: not specified, macrospcopical changes examined
Specific biochemical examinations:
NEUROPATHY TARGET ESTERASE (NTE) ACTIVITY: No

CHOLINESTERASE ACTIVITY: No
Neurobehavioural examinations performed and frequency:
Details of the examinations/behavioral determinations and the number of animals used in the test are given in table 1.

Behavioral Tests
- testing performed between 0800 h and 1400 h

Surface righting reflex
- the time taken by the pup to right itself on all four feet after it had been placed in a supine position
- maximum time allowed was 15 s; number of pups per litter to fulfill criterion was recorded daily, one trial per day on PND 1 and the following days until all pups in the litter met the criterion

Homing response (nest-seeking response mediated by the olfactory system)
- conducted on PNDs 6 and 7
- littermates and dam were removed during testing
- pup placed longitudinally on a "bridge" of plastic (8 x 20 cm) connecting the homecage and a cage with clean bedding
- pups choosing the home bedding site by crossing the edge of the "bridge" with the front paws and head were recorded as having fulfilled the criterion in the test

Auditory startle reflex
- presence or absence of starle reflex was assessed by visual observation following the delivery of a click from a BIC-pencil held at a distance of 1 cm from each ear

Air righting reflex
- pups were held in a supine position and dropped from a height of 40 cm on a 2-3 cm thick layer of home bedding
- criterion fullfilled by landing on all four feet

Rotarod
- two males per litter tested as described by Ladefoged (Ladefoged et al., Pharmacol. Toxixol. 68:384-390, 1991) with minor modifications
- speed: 10 rpm, 10 rpm, and 12 rpm on PNDs 24, 25, and 26, respectively, and the maximum time was 30 s
- rats scored for the amount of time on the rod, the percentage of animals in each group reaching the 30 s criterion

Open field
- on days 27 and 28, 2 males per litter were recorded on videotape for 3 min in a square open field (75 cm)
- videotapes analysed by means of a computer with a frame-grabber (DT2853, Data Translation), a subroutine library for image processing (OT-IRIS, Data Translation) and a lab specific program
- calculation of the total distance the animals moved in the field and the percentage time spent in the center square of the field when dividing the field into 9 squares of equal size

Morris water maze
- testing of spatial learning and retention in Morris water maze performed in a common manner
- 13 to 15 male rats used, representing 6 to 7 litters from each group
- black, circular plastic pool with a diameter of 220 cm filled to a depth of 30 cm with tap water at room temperature (20°C)
- four points on the rim of the pool, i.e., N, W, E, and S, used as starting points and for dividing the pool into four arbitrary quadrants
- circular platform (diameter 10 cm) situated on a solid support equidistant from the side and the center of the pool
- latency to reach the platform measured by stopwatch and the maximum trial latency: 60 s
- animals tested in blocks of four trials using the four starting points assigned in a pseudo-random sequence
- two cages with 4 animals placed near the pool, one animal after the other started at the first point, tested and then returned to the cage
- same procedure was repeated for the other three starting points
- when the rat swam to and climbed onto the platform, the trial was ended
- if the animal failed to locate the platform within 60 s, it was placed on the platform for 15 s and then returned to the cage
SCHEME USED
- Training: with the platform situated 1 cm above the surface of the water in the center of SW quadrant, the animals were trained for 3 blocks of 4 trials (Trials 1-12), one block per day on consecutive days
- Learning: with the platform situated 1 cm below the surface of the water at the same location in the pool, the animals were trained until a stable performance was established, i.e., 5 blocks of 4 trials (Trials 13-32) twice a day on consecutive days
- Retention: one month later, animals were tested again with the platform in the same location in the pool, 5 blocks of 4 trials (Trials 1-20), two blocks per day on consecutive days
- Transfer test: immediately after two more trials (Trials 21 and 22), the platform was removed from the pool, each animal had one trial from the same starting point, swim path was followed for 60 s, time spent in the target quadrant, expressed as a percentage of the total time, was calculated by the image analysing program
- New platform location: animals tested in a reversal procedure with the platform located in the center of the NE quadrant opposite the original location used earlier, animals were tested for 6 blocks of 4 trials on 3 consecutive days (Trials 24-47)
- Operant conditioning (delayed spatial alternation): 12 male rats (from 12 litters, 11 with median weight and 1 with low weight at weaning) from each group used, animals were transported by air-freight from Copenhagen to Zurich (total travel time of approximately 8 h) at the age of 4 months, rats were housed by four in Makrolon IV cages and the environmental conditions were: 12L: 12D cycle (light on at 6 a.m.), temperature 23 ± 1°C and relative humidity 48 ± 5%
Sacrifice and (histo)pathology:
- Time point of sacrifice: postnatal day (PND) 80 for female pups and PND 100 for male pups selected, PND 22 for rest of the pups, the dams and the sperm-positive females who had not given birth
- Number of animals sacrificed: not specified
- Brain weight: not measured
Other examinations:
- offspring weighed in the preweaning period on PNDs 1, 2, 3, 6, 7, 9, 10, 11, 12, 13, 14, 15, 16, 19, 22; weighed once every week
- sexual maturation assessed by observation of vaginal opening in females and cleavage of the balano-prepubital skinfold in the males
Statistics:
- litter or one pup per litter = statistical unit
- Mann-Whitney U test and chi-square test: body weights, developmental milestones and reflexes, results from Rotarod test
- Multivariant analyses (MANOVA): Morris maze results, operant behavior test

Results and discussion

Results of examinations

Clinical signs:
not specified
Description (incidence and severity):
Maternal animals:
- no clinical signs were seen

Pups:
- significantly delayed in some recorded developmental milestones (as described in table 4)
Mortality:
not specified
Description (incidence):
Maternal animals:
- not specified

Pups:
- no effects observed compared to the control group
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
Pups:
- from birth and throughout preweaning: mean b.w. in litters was significantly lower
- distribution of b.w. was not merely shifted to lower values also more skewed
- difference was not statistically significant after the age of 5 weeks
Results are given in table 2 and table 3.
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
effects observed, non-treatment-related
Description (incidence and severity):
- urine of the females in the exposed group was colored bright yellow
Behaviour (functional findings):
effects observed, treatment-related
Description (incidence and severity):
Behavioral effects:
- exposed pups were significantly delayed in some recorded developmental milestones and in the ontogeny of the surface righting reflex (see Table 4)
- no differences found concerning age at sexual maturation, performance on the Rotarod, or ambulation and percentage of time spent in the center square in open field
- testing for operant behavior indicated no differences in the first training phases concerning outshaping, discrete trials, or visual discrimination
- suggested reduced retention of learned behavior
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
not examined
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
not examined
Histopathological findings: neoplastic:
not examined

Effect levels

Dose descriptor:
LOAEC
Effect level:
150 ppm (analytical)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
behaviour (functional findings)
body weight and weight gain
clinical signs

Target system / organ toxicity

Critical effects observed:
no

Any other information on results incl. tables

Table 2: Pup body weights.

Body weight after weaning

 

Control

NMP

Females

Small*

 

Medium†

 

Small*

 

Medium†

 

Day 22

41± 1

 

42 ± 1

 

37 ± 1§

 

39 ± 1†

 

Day 24

45± 1

 

48 ± 1

 

41 ± 1§

 

44 ± †

 

Day 28 or 29

61 ± 2

 

65 ± 1

 

60 ± 2

 

62 ± 2

 

7-8 weeks

155± 4

 

165 ± 5

 

147 ±3

 

155 ± 4§

 

11-12 weeks

197± 5

 

210 ± 6

 

190 ± 4

 

201 ± 4

 

Males

 

 

 

 

 

 

 

 

Day 22

41± 1

 

43 ± 1

 

39 ± 1§

 

40 ± 1‡

 

Day 24

47 ± 1

 

48 ± 1

 

43 ± 1§

 

44± 1‡

 

Day 28

65 ± 1

 

68 ± 1

 

62 ± 1

 

66 ± 1

 

Day 36 (± 1)

108 ± 3

 

113 ± 3

 

104 ± 3

 

105 ± 3‡

 

7-8 weeks

218 ± 7

 

221 ± 6

 

209 ± 6

 

206 ± 7

 

11-12 weeks

335 ± 11

 

340 ± 7

 

320 ± 6

 

327 ± 7

 

14-15 weeks

368 ± 13

 

375 ± 8

 

346 ± 8

 

354 ± 8

 

*Pup with lowest body weight in litter at weaning;†Pup with median body weight in litter at weaning;‡p<0.05,Mann-Whitney U Test, NMP versus control;§p<0.10, Mann-Whitney U Test, NMP versus control; mean ± SD.

Table 3: Body weight in litters in the preweaning period.

Group

Control

NMP

Number of litters

14

16

Day 1

5.9 ± 0.4

5.5 ± 0.3*

Day 7

12.8 ± 0.9

11.9 ± 1.0*

Day 10

17.6 ± 1.3

16.6 ± 1.6*

Day 14

24.0 ± 1.7

22.6 ± 2.0*

Day 19

32.5 ± 3.2

30.S ± 2.7†

Day 22

42.2 ± 3.7

39.S ± 3.3*

*p<0.05,Mann-WhitneyU Test;p<0.10, Mann­ Whitney U Test; Mean±SD.

Table 4: Results of the developmental milestones and the reflex testing in exposed pups.

Developmental milestones and reflexes

 

 

Control

NMP

Number of litters

 

14

16

Ear unfolding

positive - day 2

2%

0%

 

positive - day 3

88%

48%*

Surface righting reflex

negative - day 1

50%

59%

 

negative - day 2

negative - day 3

41%

6%

39%

15%

 

negative - day 4

O%

3%

Homing response

positive - day 6

67%

77%

 

positive - day 7

95%

95%

Incisor eruption

positive - day 9

positive - day 10

14%

50%

8%

37%

 

positive - day 11

91%

77%

 

positive - day 12

99%

93%

Auditory startle reflex

positive - day 11

0%

0%

 

positive . day 12

11%

5%

 

positive- day 13

93%

77%

Eye opening

positive - day 13

6%

9%

 

positive - day 14

44%

43%

 

positive. day 15

98%

83%*

Air righting reflex

positive- day 14

26%

32%

 

positive. day 15

53%

49%

 

positive- day 16

98%

99%

Mean of%of litters;*p<5%,Mann-Whitney U Test;p<5%,x2-test.

Applicant's summary and conclusion

Conclusions:
The physical development of the pups was delayed based on retarded body weight gain until weaning and the results of ear unfolding, surface rightening reflex, incisor eruption and eye opening.

However, no treatment-related effects were noted on landmarks of physical development and reflexes during the later part of pre-weaning and thereafter and no effects on onset of puberty, open filed parameter and performance on rotarod.

The results of the Morris water maze and operant conditioning were contradictory since some parameter and sessions showed an impairment, while other demonstrated no differences.
Executive summary:

Pregnant rats (Mol: WIST) were exposed to 150 ppm N-methylpyrrolidone for 6 hours per day on gestation days 7-20. The dose level was selected so as not to induce maternal toxicity or decrease viability of the offspring. In the preweaning period, the exposed offspring had a lower body weight and their physical development was delayed. Neurobehavioral evaluation of the male pups revealed no effects on basal functions of the central nervous system. The animals appeared normal in motor function (rotarod), activity level (open field), and performance in learning tasks with a low grade of complexity were similar in the two groups. However, in more difficult tasks such as the reversal procedure in Morris water maze and operant delayed spatial alternation (Skinner boxes), performance was impaired in exposed offspring.